2024年3月8日 · New-onset HF (regardless of EF): Refer for evaluation of etiology, guideline-directed evaluation and management of recommended therapies, and assistance in disease …

2022年4月1日 · New treatment strategies in HF, including sodium-glucose cotransporter-2 inhibitors (SGLT2i) and angiotensin receptor-neprilysin inhibitors (ARNi).

2021年7月12日 · The new universal definition nomenclature offers opportunities for more precise communication and description of health and disease in heart failure with terms including …

2024年12月4日 · Here, we discuss these new and future heart failure drugs. We explain their mechanisms of action, critically evaluate their performance in clinical trials and summarize the …

New-onset HF in both men and women was associated with pathophysiological pathways related to neutrophil degranulation and immunomodulation; and these pathways partly mediated the …

In March 2021, the Heart Failure Society of America (HFSA), the Heart Failure Association of the European Society of Cardiology (HFA-ESC) and the Japanese Heart Failure Society (JHFS) …

2024年3月8日 · In line with recent evidence and guidelines, the recommended core guideline-directed medical therapy (GDMT) for chronic heart failure (HF) includes an angiotensin II …

Hospital admission from the ED is generally indicated for a new diagnosis of HF with rapidly progressive symptoms, severe congestion, or higher complexity of disease; some low-risk …

2022年4月1日 · New recommendations for HF with preserved EF (HFpEF) are made for SGLT2i (COR 2a), MRAs (COR 2b), and ARNi (COR 2b). Several previous recommendations have …

2022年4月2日 · During a panel at the American College of Cardiology’s (ACC) 70th Scientific Session, experts highlighted updates to the 2022 American Heart Association …